MANGALAM₹28.65-3.11%
36/100
0100 · strongest
moderate
Weights come from configuration, not from this page — each pillar links to the section below that explains it.
Income stmtHistory
Profitability
headline ratiosGrowth
compounded, from filed annual resultsSegment Results
₹ CrWorking Capital & Efficiency
days · ROCE %MANGALAM financial summary
For Mar 2026, Mangalam Drugs & Organics Ltd reported revenue of ₹232 crore, which fell 27.0% from the previous year. Net profit was -₹44 crore, which fell 728.6% year on year, on an operating margin of -6%. Earnings per share came in at -₹27.68. Annual results are available for 14 financial years, from Mar 2013 to Mar 2026.
| Revenue | ₹232 crore |
|---|---|
| Net profit | -₹44 crore |
| Operating margin | -6% |
| EPS | -₹27.68 |